PubMed Health⌕ Search

Biomedical subjects

Y Tatsu

Publications and source records attributed to Y Tatsu.

26 records · Page 2Linked to original sources
PubMed1993

[Clinical efficacy of 99mTc-tetrofosmin myocardial scintigraphy--comparison to 201Tl myocardial scintigraphy].

99mTc-tetrofosmin is a lipophilic, cationic diphosphine which has been developed for myocardial imaging. We examined 9 patients with ischemic heart disease including 3 angina pectoris (AP), 4 old myocardial infarction (OMI), 1 AP with OMI and 1 syndrome X. One patient was examined before and after operation. 370 MBq of 99mTc-tetrofosmin was injected during exercise and 740 MBq at rest. And 74 MBq of 201Tl myocardial exercise and redistribution scintigraphy was also performed to compare with 99mTc-tetrofosmin myocardial scintigraphy. SPECT, multiple gated SPECT and anterior planar images were obtained in all cases. We calculated percent wall thickening (%WT) using multiple gated SPECT images. There was a decreased lung uptake in 99mTc-tetrofosmin planar images compared to 201Tl myocardial scintigraphy. Liver and Biliary system uptake in 99mTc-tetrofosmin images was decreased with intake of milk. Segmental comparison of SPECT images showed an agreement in 9/10 of the segment between 201Tl and 99mTc-tetrofosmin. We could obtain excellent quality of multiple gated SPECT images in all patients. We could calculate percent wall thickening (%WT) in all patients. We conclude that 99mTc-tetrofosmin myocardial scintigraphy should provide usefulness for detection of ischemic myocardium as same as 201Tl myocardial scintigraphy, although the biologic characteristics of two agents were different. These data and excellent quality of multiple gated SPECT images suggest that 99mTc-tetrofosmin is a new 99mTc agent for evaluation of patients with ischemic heart disease.

Exercise Test↗
PubMed1993

[Evaluation of 99mTc-HM-PAO thigh accumulation in patients with cerebro-vascular disease].

99mTc-HM-PAO cerebral SPECT and whole body scintigraphy (WBS) were performed in 5 patients without cerebro-vascular disease (CVD) (Group 1), 31 patients with CVD but not hemiparesis (Group 2) and 18 patients with CVD and hemiparesis (Group 3). Four ROIs were drawn manually around the whole body (WB), brain (Br), right and left thigh (Th). We calculated some ratios: the total counts in the brain over the total counts in the whole body (Br/WB), the total counts in the thigh over the total counts in the whole body (Th/WB) and the mean counts in the thigh over the mean counts in the brain (Th/Br). The Br/WB was 6.9 +/- 1.8%, rt-Th/WB was 4.9 +/- 2.1%, lt-Th/WB was 5.1 +/- 1.3% and Th/Br was 0.46 +/- 0.17 in group 1. Whole body scintigraphies in group 1 revealed clear and similar images between right and left thigh. The Br/WB was 6.7 +/- 1.4%, Th/WB of paretic side was 4.6 +/- 1.0%, Th/WB of non-paretic side was 5.8 +/- 1.2% and Th/Br was 0.47 +/- 0.18 in group 3. The Th/WB in non paretic side was significantly higher than that in paretic side (p < 0.01). The thigh images in group 3 revealed clearly different between paretic and non-paretic thigh. In conclusion we could acquire the clear thigh images with 99mTc-HM-PAO. It was possible that we evaluated not only cerebral perfusion but also muscle atrophy and/or perfusion in patients with CVD using 99mTC-HM-PAO.

Adult↗
PubMed1993

[512 x 2048 matrix whole body scintigraphy with laser imaging system].

Although we could acquire a detailed 512 x 2048 matrix whole body scintigraphy, the 512 x 2048 matrix whole body scintigraphy was divided to the upper and lower half of the body, because a many of CRT system displayed only 1024 x 1024 matrix with non interlace mode. We made 12 dots of normal vertical image distance to 0 dot with laser imaging system (Li-10 Konica medical inc.), and we printed these divided whole body images in the four partition of the film. The lead bar phantom (interval from 6 mm to 3 mm) filled with 99mTcO4- was studied by both 512 x 2048 matrix whole body scanning mode and 256 x 1024 whole body scanning mode in the basic study. And the distance between the lead bar phantom and the gamma camera was changed from 10 mm to 100 mm. We studied 41 patients with metastatic bone tumor (14 breast cancer, 7 lung cancer, 7 prostate cancer, 5 others, 6 unknown origin) clinically. However the 512 x 2048 matrix whole body scan was better quality of images than 256 x 1024 matrix whole body scan at 100 mm distance in the basic study. The abnormal uptake of metastatic sites was shown equally in both 512 x 2048 and 256 x 1024 matrix whole body scintigraphy. The 512 x 2048 matrix whole body scan was better quality of images than 256 x 1024 matrix whole body scan in 26 out of 41 patients, equal in 10 out of 41 patients and worse in 3 out of 41 patients. The matrix size of 512 x 2048 matrix whole body scintigraphy (0.98 mm2) was smaller than that of 256 x 1024 matrix whole body scintigraphy (1.95 mm2).(ABSTRACT TRUNCATED AT 250 WORDS)

Bone and Bones↗
PubMed1992

Fluorescent fibre-optic immunosensing system based on complement lysis of liposome containing carboxyfluorescein.

A novel type of fibre-optic immunosensing system has been developed. Agar gel-immobilized liposomes containing carboxyfluorescein were attached to the tip of an optical fibre. Complement-mediated immunolysis of the liposome was fluorometrically detected through the fibre. By using dinitrophenyl (DNP) hapten-loaded liposomes, concentrations as low as 500-fold diluted anti-DNP antibody and 0.76 CH50 ml-1 of complement were detected.

Biosensing Techniques↗
PubMed1990

Homogeneous chemiluminescent immunoassay based on complement-mediated hemolysis of red blood cells.

A novel method was developed for the homogeneous chemiluminescent immunoassay using complement-mediated hemolysis of sheep red blood cells. The chemiluminescent reaction of luminol and H2O2 was catalyzed by hemoglobins leaked from hemolyzed sheep red blood cells. The chemiluminescence was measured by counting photons. When using nonhemolyzed cells, chemiluminescence was virtually not observed. Only hemoglobin released from the cells was chemiluminescent, so that the extent of hemolysis could be measured without separating hemolyzed and nonhemolyzed cells. The immunoassay was done for the immunoagents: complement, hemolysin (anti-sheep red blood cell antibody), and anti-human albumin antibody. In the assay of complement or anti-human albumin antibody, sheep red blood cells used were bound with hemolysin or human albumin, respectively. The cell was hemolyzed by the action of antigen-antibody binding and subsequent activation of complement. The extent of hemolysis depended on the concentration of the antibody or complement. The calibration curves were obtained by chemiluminometric measurements on the added diluted antibody or complement. The sensitivity was 0.047 CH50 unit/mL for complement and below 1.0 micrograms/mL of anti-human albumin antibody.

Animals↗
PubMedDate not supplied

Helical scanning CT for hepatocellular carcinoma.

To evaluate the clinical usefulness of helical scanning CT for hepatocellular carcinoma, 39 patients were examined using a Toshiba CT system, the Xforce. Helical scanning CT data were acquired using up to 20 continuous 1.5-sec rotations, with contrast medium bolus injection of 100-150 ml at a rate of 1.5-3 ml/sec, and during a single breath-hold. Scanning was begun 35 to 50 sec after the start of injection. Helical scanning CT permits axial images to be reconstructed at any desired position within the scanned area, and provides images without interslice gaps caused by respiratory movement. Contrast enhanced helical scanning CT permits blood vessels to be clearly displayed following the bolus injection of contrast medium using an automatic injector. Furthermore, the shorter scanning time makes it possible to scan the target area in the desired vascular phase. In all 39 patients who were examined using contrast enhanced helical scanning CT, high-quality three-dimensional images were obtained. Such images were particularly useful for assessing the three-dimensional relationships among high density tumors and vascular structures. In conclusion, helical scanning CT was considered to be useful for hepatocellular carcinoma.

Aged↗